Πλοήγηση ανά Θέμα "adverse outcome"
Αποτελέσματα 1-9 από 9
-
Bronchial Asthma and Sarcopenia: An Upcoming Potential Interaction
(2022)Background: Sarcopenia seems to be an emerging health issue worldwide, concerning the progressive loss of skeletal muscle mass, accompanied by adverse outcomes. Asthma is a chronic inflammatory respiratory condition that ... -
The current evidence regarding covid‐19 and pregnancy: Where are we now and where should we head to next?
(2021)Despite the volume of publications dedicated to unraveling the biological characteristics and clinical manifestations of SARS‐CoV‐2, available data on pregnant patients are limited. In the current review of literature, we ... -
The effect of in-hospital acquired thrombocytopenia on the outcome of patients with acute coronary syndromes: A systematic review and meta-analysis
(2016)Background In-hospital acquired thrombocytopenia (TP) is relatively common among patients hospitalized with acute coronary syndromes (ACS). However, its effect on short-term and long-term outcomes has yet to be reviewed ... -
Inflammation, Hyperglycemia, and Adverse Outcomes in Individuals With Diabetes Mellitus Hospitalized for COVID-19
(2022)OBJECTIVE Diabetes mellitus (DM) is a major risk factor for severe coronavirus disease 2019 (COVID-19) for reasons that are unclear. RESEARCH DESIGN AND METHODS We leveraged the International Study of Inflammation in ... -
Oxidative stress in the critically ill patients: Pathophysiology and potential interventions
(2018)[No abstract available] -
A second wave of COVID-19 infections should not lead to a new disruption of services in nuclear cardiology
(2020)[No abstract available] -
A single center experience in pediatric cardiomyopathy. Risk factors, outcomes and the effect of levosimendan
(2020)Cardiomyopathies are the leading cause of heart failure (HF) in children with anatomically intact hearts. A retrospective data analysis of a tertiary cardiac surgery and cardiology center cohort was performed. Our objectives ... -
Thrombosis and Haemostasis challenges in COVID-19 – Therapeutic perspectives of heparin and tissue-type plasminogen activator and potential toxicological reactions-a mini review
(2021)The coronavirus disease (COVID)-19 pandemic is a major challenge for the health systems worldwide. Acute respiratory distress syndrome (ARDS), is one of the most common complications of the COVID-19 infection. The activation ... -
Tumor-treating fields as a fourth treating modality for glioblastoma: a meta-analysis
(2018)Background: We aim to review the available literature on patients suffering from glioblastoma treated with tumor-treating fields (TTFields) plus radio chemotherapy or conventional radio chemotherapy alone, to compare the ...